WuXi Biologics
Offering End-to-End Solutions
The in vitro and in vivo characterization of ADCs (Antibody-Drug Conjugates) during early-stage R&D is critical to ensure the selection of efficacious and safe drug candidates. WuXi Biologics offers comprehensive, one-stop in vitro and in vivo characterization services to assist our clients and enable them to discover the ideal ADC candidate to move into CMC development and on to clinical trials. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?